| Preoperative risk factors for postoperative delirium following hip fracture repair: a systematic review ES Oh, M Li, TM Fafowora, SK Inouye, CH Chen, LM Rosman, ... International journal of geriatric psychiatry 30 (9), 900-910, 2015 | 180 | 2015 |
| The feelings about genomiC testing results (factor) questionnaire: development and preliminary validation M Li, CS Bennette, LM Amendola, M Ragan Hart, P Heagerty, B Comstock, ... Journal of genetic counseling 28 (2), 477-490, 2019 | 59 | 2019 |
| Impact of Cold Ischemia Time on Outcomes of Liver Transplantation: A Single Center Experience. L Sibulesky, M Li, RN Hansen, AA Dick, MI Montenovo, SC Rayhill, ... Annals of transplantation 21, 145-151, 2016 | 46 | 2016 |
| Using performance-based risk-sharing arrangements to address uncertainty in indication-based pricing K Yeung, M Li, JJ Carlson Journal of managed care & specialty pharmacy 23 (10), 1010-1015, 2017 | 39 | 2017 |
| An evaluation of health care expenditures in Crohn's disease using the United States medical expenditure panel survey from 2003 to 2013 M Bounthavong, M Li, JH Watanabe Research in Social and Administrative Pharmacy 13 (3), 530-538, 2017 | 39 | 2017 |
| Cost‐effectiveness of liver transplantation in methylmalonic and propionic acidemias M Li, A Dick, M Montenovo, S Horslen, R Hansen Liver Transplantation 21 (9), 1208-1218, 2015 | 30 | 2015 |
| Augmenting cost-effectiveness analysis for uncertainty: the implications for value assessment—rationale and empirical support LP Garrison Jr, B Zamora, M Li, A Towse Journal of managed care & specialty pharmacy 26 (4), 400-406, 2020 | 28 | 2020 |
| A cost-effectiveness analysis between amlodipine and angiotensin ii receptor blockers in stroke and myocardial infarction prevention among hypertension patients in China Y Wu, Q Zhou, J Xuan, M Li, S Zelt, Y Huang, H Yin, M Huang Value in health regional issues 2 (1), 75-80, 2013 | 25 | 2013 |
| Do cancer treatments have option value? Real‐world evidence from metastatic melanoma M Li, A Basu, CS Bennette, DL Veenstra, LP Garrison Health Economics 28 (7), 855-867, 2019 | 21 | 2019 |
| Growing financial burden from high-cost targeted oral anticancer medicines among medicare beneficiaries with cancer M Li, K Liao, IW Pan, YCT Shih JCO oncology practice 18 (11), e1739-e1749, 2022 | 19 | 2022 |
| Estimating the cost of illness of giant cell arteritis in the United States JB Babigumira, M Li, DM Boudreau, JH Best, LP Garrison Rheumatology and Therapy 4, 111-119, 2017 | 19 | 2017 |
| Cryo-EM structure of a tetrameric photosystem I from Chroococcidiopsis TS-821, a thermophilic, unicellular, non-heterocyst-forming cyanobacterium DA Semchonok, J Mondal, CJ Cooper, K Schlum, M Li, M Amin, ... Plant Communications 3 (1), 2022 | 18 | 2022 |
| Acceptability of cervical cancer screening using visual inspection among women attending a childhood immunization clinic in Uganda M Li, A Nyabigambo, P Navvuga, E Nuwamanya, A Nuwasiima, ... Papillomavirus Research 4, 17-21, 2017 | 17 | 2017 |
| How does option value affect the potential cost-effectiveness of a treatment? The case of ipilimumab for metastatic melanoma M Li, A Basu, C Bennette, D Veenstra, LP Garrison Jr Value in Health 22 (7), 777-784, 2019 | 16 | 2019 |
| A pragmatic guide to assessing real option value for medical technologies M Li, L Garrison Jr, W Lee, S Kowal, W Wong, D Veenstra Value in Health 25 (11), 1878-1884, 2022 | 12 | 2022 |
| Association of drug rebates and competition with out-of-pocket coinsurance in Medicare Part D, 2014 to 2018 D Lakdawalla, M Li JAMA network open 4 (5), e219030-e219030, 2021 | 11 | 2021 |
| Association between spending and outcomes for patients with cancer M Li, DN Lakdawalla, DP Goldman Journal of Clinical Oncology 38 (4), 323, 2020 | 10 | 2020 |
| Real-world evidence for option value in metastatic melanoma WB Wong, TM To, M Li, W Lee, DL Veenstra, LP Garrison Jr Journal of Managed Care & Specialty Pharmacy 27 (11), 1546-1555, 2021 | 9 | 2021 |
| Spending On Targeted Therapies Reduced Mortality In Patients With Advanced-Stage Breast Cancer: Study examines spending on targeted therapies for patients with advanced-stage … M Li, DP Goldman, AJ Chen Health Affairs 40 (5), 763-771, 2021 | 8 | 2021 |
| Assessment of the scope and practice of evaluation among medical donation programs AM Jenny, M Li, E Ashbourne, M Aldrink, C Funk, A Stergachis Globalization and Health 12, 1-6, 2016 | 8 | 2016 |
